• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤细胞系中 p53 依赖性 G1 检验点功能缺陷的预后标志。

A prognostic signature of defective p53-dependent G1 checkpoint function in melanoma cell lines.

机构信息

Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

出版信息

Pigment Cell Melanoma Res. 2012 Jul;25(4):514-26. doi: 10.1111/j.1755-148X.2012.01010.x. Epub 2012 Jun 1.

DOI:10.1111/j.1755-148X.2012.01010.x
PMID:22540896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3397470/
Abstract

Melanoma cell lines and normal human melanocytes (NHM) were assayed for p53-dependent G1 checkpoint response to ionizing radiation (IR)-induced DNA damage. Sixty-six percent of melanoma cell lines displayed a defective G1 checkpoint. Checkpoint function was correlated with sensitivity to IR with checkpoint-defective lines being radio-resistant. Microarray analysis identified 316 probes whose expression was correlated with G1 checkpoint function in melanoma lines (P≤0.007) including p53 transactivation targets CDKN1A, DDB2, and RRM2B. The 316 probe list predicted G1 checkpoint function of the melanoma lines with 86% accuracy using a binary analysis and 91% accuracy using a continuous analysis. When applied to microarray data from primary melanomas, the 316 probe list was prognostic of 4-yr distant metastasis-free survival. Thus, p53 function, radio-sensitivity, and metastatic spread may be estimated in melanomas from a signature of gene expression.

摘要

黑色素瘤细胞系和正常人黑色素细胞(NHM)被检测到对电离辐射(IR)诱导的 DNA 损伤的 p53 依赖性 G1 检查点反应。66%的黑色素瘤细胞系显示 G1 检查点缺陷。检查点功能与对 IR 的敏感性相关,具有检查点缺陷的细胞系具有抗辐射性。微阵列分析确定了 316 个探针,其表达与黑色素瘤细胞系中的 G1 检查点功能相关(P≤0.007),包括 p53 反式激活靶标 CDKN1A、DDB2 和 RRM2B。该 316 个探针列表使用二进制分析预测黑色素瘤细胞系的 G1 检查点功能的准确率为 86%,使用连续分析的准确率为 91%。当应用于原发性黑色素瘤的微阵列数据时,该 316 个探针列表可预测 4 年无远处转移的生存情况。因此,p53 功能、放射敏感性和转移扩散可以通过基因表达的特征来估计黑色素瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cfe/3397470/1ab674674093/nihms384421f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cfe/3397470/deabf114e2fd/nihms384421f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cfe/3397470/d641c3a24366/nihms384421f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cfe/3397470/0effe44209b8/nihms384421f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cfe/3397470/1f776bba53f6/nihms384421f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cfe/3397470/1ab674674093/nihms384421f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cfe/3397470/deabf114e2fd/nihms384421f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cfe/3397470/d641c3a24366/nihms384421f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cfe/3397470/0effe44209b8/nihms384421f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cfe/3397470/1f776bba53f6/nihms384421f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cfe/3397470/1ab674674093/nihms384421f5.jpg

相似文献

1
A prognostic signature of defective p53-dependent G1 checkpoint function in melanoma cell lines.黑色素瘤细胞系中 p53 依赖性 G1 检验点功能缺陷的预后标志。
Pigment Cell Melanoma Res. 2012 Jul;25(4):514-26. doi: 10.1111/j.1755-148X.2012.01010.x. Epub 2012 Jun 1.
2
Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression.黑色素瘤中细胞周期检查点功能缺陷与基因表达模式改变有关。
J Invest Dermatol. 2008 Jan;128(1):175-87. doi: 10.1038/sj.jid.5700935. Epub 2007 Jun 28.
3
A prognostic signature of G(2) checkpoint function in melanoma cell lines.黑色素瘤细胞系中 G(2)检验点功能的预后特征。
Cell Cycle. 2013 Apr 1;12(7):1071-82. doi: 10.4161/cc.24067. Epub 2013 Mar 1.
4
Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B.黑色素瘤中控制G1/S细胞周期的基因的突变分析:TP53、CDKN1A、CDKN2A和CDKN2B。
BMC Cancer. 2005 Apr 8;5:36. doi: 10.1186/1471-2407-5-36.
5
The role of cell cycle regulatory proteins in the pathogenesis of melanoma.细胞周期调节蛋白在黑色素瘤发病机制中的作用。
Pathology. 2006 Aug;38(4):287-301. doi: 10.1080/00313020600817951.
6
Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression.黑色素瘤进展中的衰老逃逸:DNA 损伤信号与 p53 激活和 p21 表达的解偶联。
Pigment Cell Melanoma Res. 2013 Mar;26(2):226-35. doi: 10.1111/pcmr.12060. Epub 2013 Jan 14.
7
Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma.p53、rb、p21/waf-1、p16/ink-4a和PTEN肿瘤抑制因子在犬黑色素瘤中的表达及意义
Vet Pathol. 2002 Jul;39(4):458-72. doi: 10.1354/vp.39-4-458.
8
Dominant effects of Δ40p53 on p53 function and melanoma cell fate.Δ40p53 对 p53 功能和黑色素瘤细胞命运的主导作用。
J Invest Dermatol. 2014 Mar;134(3):791-800. doi: 10.1038/jid.2013.391. Epub 2013 Sep 13.
9
Nucleosome assembly protein 1-like 4, a new therapeutic target for proliferation and invasion of melanoma cells.核小体组装蛋白 1 样蛋白 4 是一种治疗黑素瘤细胞增殖和侵袭的新靶点。
J Dermatol Sci. 2021 Apr;102(1):16-24. doi: 10.1016/j.jdermsci.2021.02.001. Epub 2021 Feb 5.
10
Dual inactivation of RB and p53 pathways in RAS-induced melanomas.RAS诱导的黑色素瘤中RB和p53通路的双重失活。
Mol Cell Biol. 2001 Mar;21(6):2144-53. doi: 10.1128/MCB.21.6.2144-2153.2001.

引用本文的文献

1
Bioinformatic Characterization of the Functional and Structural Effect of Single Nucleotide Mutations in Patients with High-Grade Glioma.高级别胶质瘤患者单核苷酸突变功能和结构效应的生物信息学特征分析
Biomedicines. 2024 Oct 9;12(10):2287. doi: 10.3390/biomedicines12102287.
2
Roles of UVA radiation and DNA damage responses in melanoma pathogenesis.UVA辐射与DNA损伤反应在黑色素瘤发病机制中的作用。
Environ Mol Mutagen. 2018 Jun;59(5):438-460. doi: 10.1002/em.22176. Epub 2018 Feb 21.
3
Bayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancer.信号重新布线的贝叶斯模型揭示了乳腺癌获得性耐药中基因失调的机制。
PLoS One. 2017 Mar 13;12(3):e0173331. doi: 10.1371/journal.pone.0173331. eCollection 2017.
4
ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment.ATR突变通过调节免疫微环境促进黑色素瘤肿瘤生长。
Cell Rep. 2017 Mar 7;18(10):2331-2342. doi: 10.1016/j.celrep.2017.02.040.
5
Synthetic lethality: emerging targets and opportunities in melanoma.合成致死性:黑色素瘤中的新兴靶点与机遇
Pigment Cell Melanoma Res. 2017 Mar;30(2):183-193. doi: 10.1111/pcmr.12573. Epub 2017 Mar 11.
6
Effective intra-S checkpoint responses to UVC in primary human melanocytes and melanoma cell lines.原代人黑素细胞和黑色素瘤细胞系中对紫外线C的有效细胞内S期检查点反应。
Pigment Cell Melanoma Res. 2016 Jan;29(1):68-80. doi: 10.1111/pcmr.12426. Epub 2015 Nov 3.
7
Oncogenic BRAF(V600E) Induces Clastogenesis and UVB Hypersensitivity.致癌性 BRAF(V600E) 诱导细胞碎裂和 UVB 超敏反应。
Cancers (Basel). 2015 Jun 17;7(2):1072-90. doi: 10.3390/cancers7020825.
8
IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.白细胞介素-2诱导型T细胞激酶,黑色素瘤的新型治疗靶点。
Clin Cancer Res. 2015 May 1;21(9):2167-76. doi: 10.1158/1078-0432.CCR-14-1826.
9
Vascular channels formed by subpopulations of PECAM1+ melanoma cells.由PECAM1+黑色素瘤细胞亚群形成的血管通道。
Nat Commun. 2014 Oct 22;5:5200. doi: 10.1038/ncomms6200.
10
Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment.对一名长期接受BRAF抑制剂治疗的BRAF突变型黑色素瘤患者进行耐药监测。
Melanoma Res. 2014 Aug;24(4):408-12. doi: 10.1097/CMR.0000000000000085.

本文引用的文献

1
p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition.通过 HDM2 拮抗作用拯救 p53 抑制黑色素瘤生长并增强 MEK 抑制作用。
J Invest Dermatol. 2012 Feb;132(2):356-64. doi: 10.1038/jid.2011.313. Epub 2011 Oct 13.
2
Introduction: The Changing Directions of p53 Research.引言:p53研究的发展方向转变
Genes Cancer. 2011 Apr;2(4):382-4. doi: 10.1177/1947601911413463.
3
Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression.没有永生的恶性肿瘤?细胞永生化可能是黑色素瘤进展中的晚期事件。
Pigment Cell Melanoma Res. 2011 Jun;24(3):490-503. doi: 10.1111/j.1755-148X.2011.00850.x. Epub 2011 Apr 20.
4
Hallmarks of cancer: the next generation.癌症的特征:下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
5
Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032.黑色素瘤细胞对电离辐射的敏感性表现出异质性,用 PLX-4032 抑制 B-RAF 可增强其放射敏感性。
Radiother Oncol. 2011 Mar;98(3):394-9. doi: 10.1016/j.radonc.2010.12.017. Epub 2011 Feb 4.
6
p53 and its mutants in tumor cell migration and invasion.p53 及其突变体在肿瘤细胞迁移和侵袭中的作用。
J Cell Biol. 2011 Jan 24;192(2):209-18. doi: 10.1083/jcb.201009059.
7
Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics.释放刹车导致的死亡:CHK1 抑制剂作为癌症治疗药物。
Trends Mol Med. 2011 Feb;17(2):88-96. doi: 10.1016/j.molmed.2010.10.009. Epub 2010 Nov 17.
8
p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation.p53 主要通过细胞周期调控来阻止痣进展为黑色素瘤。
Pigment Cell Melanoma Res. 2010 Dec;23(6):781-94. doi: 10.1111/j.1755-148X.2010.00773.x.
9
Cancer stem cells versus phenotype-switching in melanoma.癌症干细胞与黑色素瘤中的表型转换。
Pigment Cell Melanoma Res. 2010 Dec;23(6):746-59. doi: 10.1111/j.1755-148X.2010.00757.x. Epub 2010 Aug 20.
10
A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response.p53 诱导的一个大型基因间非编码 RNA 介导 p53 应答中的全基因组基因沉默。
Cell. 2010 Aug 6;142(3):409-19. doi: 10.1016/j.cell.2010.06.040.